Kela: Contrary to Reports, the Basic Income Experiment in Finland Will Continue until the End of 2018
Many international media-outlets have published stories alleging that Finland is going to discontinue its basic income experiment. This information is incorrect.
“The experiment is proceeding according to plan and will continue until the end of 2018”, says Professor Olli Kangas , the leader of the research team at Kela (Social Insurance Institution of Finland).
There are currently no plans to continue or expand the experiment after 2018.
The effects will be studied after the experiment has ended
The employment effects across the whole experiment will be available by the end of 2019 or at the beginning of 2020.
“The effects of the experiment will not be published while the experiment is in progress, because a public discussion of the results could influence the behaviour of the test and control groups. That would lead to skewed results”, Kangas says.
The basic income experiment was launched in January 2017. During the experiment, the 2,000 participants are receiving a EUR 560 monthly basic income payment, which is independent of any other income they may have and not conditional on undertaking an active search for employment.
The purpose of the experiment is to study the effect of increasing cash incentives for work and simplifying the social security system on the employment rate of the study participants. The study will also look at the well-being of the participants and their experiences when communicating and conducting business with the authorities.
Professor Olli Kangas
+358 400 261158
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
AURAK15.12.2018 11:51 | Pressemeddelelse
AURAK Gains SACSCOC Accreditation
KRAMER-LEVIN14.12.2018 18:44 | Pressemeddelelse
Lehman Brothers Treasury Announces Plans for Partial Wind-Down
MA-TAKEDA-PHARMACEUTICAL14.12.2018 18:02 | Pressemeddelelse
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD
FL-POTNETWORK-HOLDINGS14.12.2018 16:44 | Pressemeddelelse
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules
HENLEY-&-PARTNERS14.12.2018 15:02 | Pressemeddelelse
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth
BOEHRINGER-INGELHEIM14.12.2018 10:09 | Pressemeddelelse
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum